NIH-funded research R01 grant

Understanding how chromatin fragments move in aging and senescence

Official title: Nucleus-to-cytoplasm trafficking of chromatin fragments in senescence and aging

Funded at Massachusetts General Hospital · NIH-11079659 · Data updated 2026-11-12

This study is looking at how tiny pieces of DNA in aging cells can move out of the cell's nucleus and cause inflammation, which can make it harder for the body to heal and stay healthy as we get older; the goal is to find new ways to help older adults feel better by targeting these processes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$539,708
NIH project number5R01AG082785-03
Project IDNIH-11079659 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing age-related diseases or conditions associated with cellular senescence.

Less likely to help

Patients who are not experiencing age-related conditions or are younger individuals may not benefit from this research.

What this research studies

This research investigates the movement of chromatin fragments from the nucleus to the cytoplasm in cells that are aging or have entered a state of senescence. It focuses on how these fragments contribute to inflammation and impair tissue renewal, which are common issues in age-related diseases. By studying the mechanisms behind this process, the research aims to identify potential therapeutic targets that could help clear senescent cells and improve health outcomes for older adults. The approach includes using genetic and pharmacological tools to manipulate these cellular processes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that promote healthy aging and reduce the impact of age-related diseases.

How similar studies have gone: Other research has shown success in targeting the senescence-associated secretory phenotype (SASP) and its role in aging, indicating that this approach has potential.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Dou, Zhixun — Massachusetts General Hospital
  • Study coordinator: Dou, Zhixun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.